New Drug Applications Archive - April 2007
Get news by email or subscribe to our news feeds.
April 2, 2007
- EPIX Provides Update Regarding Status of Vasovist Appeal
- Cephalon Provides Update Related to Nuvigil New Drug Application
April 3, 2007
- IDM Pharma Inc. Announces Oncologic Drugs Advisory Committee Meeting for Junovan (Mifamurtide) Will Take Place on May 9, 2007
- CSL Biotherapies Submits BLA to Introduce Flu Vaccine to U.S. Market
April 4, 2007
April 6, 2007
April 9, 2007
April 10, 2007
April 11, 2007
- Neurochem's Eprodisate (Kiacta) PDUFA Date Extended Three Months by FDA
- Statement by Merck & Co., Inc. Regarding FDA Arthritis Drugs Advisory Committee Meeting on Arcoxia (etoricoxib)
- Pro-Pharmaceuticals Receives Letter from the FDA for New Drug Application for Davanat/ 5-FU
April 12, 2007
April 13, 2007
- Skyepharma PLC - Once-Daily Requip (ropinirole HCl) XL 24-Hour Extended-Release Tablets Accepted for Filing by U.S. FDA
- Public Citizen: FDA Should Not Approve "Offspring of Vioxx" Painkiller
April 16, 2007
April 17, 2007
April 20, 2007
April 23, 2007
April 24, 2007
April 25, 2007
- FDA Advisory Committee Recommends Accelerated Approval of Pfizer’s Maraviroc for Treatment-Experienced Patients
- Solvay Pharmaceuticals Files Tedisamil, a New Cardiometabolic Product for the Treatment of Atrial Fibrillation and Atrial Flutter
